New Black Book study shows rising customer expectations and lower satisfaction rates based on provider technology

Comprehensive Interrogation of the Genetic Determinants of Female and Male Infertility: A New NGS Research Application Enabled by Improvements in Target Enrichment Technology

This webinar will offer best practices for UAT for sponsor organizations with the aim of changing the conversations and expectations around the UAT process

Thirty percent of practices with over 11 clinicians expect to replace their current system by 2021 for customization issues

According to the 2017 Tufts eClinical Landscape Study, 97% of companies plan to increase use of at least one clinical data source over the next three years. But today, 98% of companies report challenges with their clinical data management systems.

Duplicate and fragmented shared patient records are progressively putting patient safety at risk and afflict provider bottom lines.

Live interactive session will focus on how technology can help clinical trial leaders move the needs of the patient and the site to the center of the clinical trial

Achieving Orphan Drug Designation is a significant step enabling your product to be licensed faster, in a cost-efficient manner, and achieve market exclusivity for 10 years.

The race is on for non-alcoholic steatohepatitis (NASH) drug development as the disease—which has no approved treatments—is rapidly growing in prevalence and is the fastest rising cause of liver transplantation in the United States.

Bring your own device (BYOD) solutions offer a disruptive alternative to the costly provisioned solutions for ePRO but have been mostly overlooked and only moderately considered due, in part, to this question of equivalence and to concerns for patients accepting study tools on their own phones.

Webinar describes how Agios Pharmaceuticals is solving business and data challenges by implementing a Clinical Data Hub including key selection criteria, implementation best practices, and lessons learned.

Patient engagement experts from Bracket and Boehringer-Ingelheim to discuss technology selection and implementation strategies for clinical trials.

Experts from Comprehend and Tufts CSDD to discuss the recent study, outline where the industry is headed and ways to overcome oversight challenges including transparency, risk, and compliance

BioMauris becomes only fifth company with a state-level cannabis contract

Integrated and Managed Best-in-Class Hardware & Software Platforms to drive Efficiency, Savings and Simplicity for Hospitals, Clinicians and Patients

Executives share groundbreaking research on the use of longitudinal patient information to improve quality reporting at HIMSS 2018

Presenters discuss how clinical innovators, Market Access, IT and HEOR can accelerate RWE initiatives and the implications for data security and healthcare decision-making

Across eighteen key performance indicators, McKesson's iKnowMedSM retains its top satisfaction rating for the seventh consecutive year.

Allie Berner Appointed to Fill New Position

It's a matter of patient safety, quality care, workflow efficiency and care equality.

Dr. Vivek Bhatt joins the Board of Directors of pioneering healthcare technology startup, healthio

How ICH E6(R2) has given clinical development organizations the perfect opportunity to improve quality and lower costs through adoption of RBM and Centralized Monitoring.

This live webinar upcoming on February 28, 2018, is a must for anyone who is involved in the preparation of clinical evaluation reports (CERs) for medical devices. The presenters will cover practical, proven methods for conducting audit-ready literature reviews as part of the CER preparation process and will demonstrate these best practices using DistillerSR literature review software.

North Metro Medical Center integrates Rectangle Health's cutting-edge "Practice Management Bridge™" software

Healthcare IT research firm's sweeping worldwide study reveals rapidly advancing opportunities for US-based and local tech vendors

With so much at stake, where do you start when considering the right long-term strategic CRO partner? With technology and the market both priming CROs to step in as industry innovators, what attributes should sponsors look for in 'best-in-class' strategic partners?